Aurobindo Pharma has the highest Active Pharmaceutical Ingredients Market Share. Patent expiration of a drug leads to its generic version and the manufacturers bear the cost. This decreases the overall cost of the ingredient thereby increasing the number of users, which further increases the global market for the parts.
Patent expiries of the branded drugs, increased uptake of biologics, government initiatives for biomedical research are majorly driving the Active Pharmaceutical Ingredients Market. However, Unfavourable Drug Price Control Policies across Various Countries is holding back the growth of the market.
By type, the market is divided into Synthetic API and Biotech API.
Biotech APIs include Monoclonal Antibodies, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Synthetic Immunomodulators, Vaccines, Recombinant Enzymes, Antibiotics, Statins, and Others.
By manufacturing type, the market is divided into Captive and Merchant.
Captive API is the largest segment covering a significant part of the API market with a market share of approximately 61% while the remaining is taken by Merchant API.
By End User, the market is classified into-Patients with chronical diseases, Physicians, Hetero Labs, Pharmaceutical companies, Hospitals, Parents/Relatives, and Others.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year we have secured more than 100 unique customers from established organizations all over the world.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
